Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Medical College of Wisconsin
Children's Oncology Group
Wake Forest University Health Sciences
National Cancer Institute (NCI)
University of South Florida